Article Sidebar
Date Published:
11/07/2022
Online Published:
11/07/2022
Abstract Views: 53
Views PDF: 298
Views PDF: 298
Issue
Section
Scientific research
How to Cite
Bui, V. L., & Le, T. L. (2022). TÁC DỤNG KHÔNG MONG MUỐN TRONG CHỤP CỘNG HƯỞNG TỪ (MRI). Vietnamese Journal of Radiology and Nuclear Medicine, 11, 490-495. https://doi.org/10.55046/vjrnm.11.307.2013
TÁC DỤNG KHÔNG MONG MUỐN TRONG CHỤP CỘNG HƯỞNG TỪ (MRI)
Main Article Content
Article Details
References
TÀI LIỆU THAM KHẢO
1. KANAL E. Salety considerations in MR Imaging. Raliology 1990, 176: 593-606.
2. POHOST GM, BLACKWELL GG, SHEUOCK FG. Safety of patients with medical devices during application of magnetic resonance methods. Ann N Y Acad Sci 1992, 649: 302-312.
3. KANAL E. An overview of electromagnetic safety considerations associated with magnetic resonance imaging. Ann N Y Acad Sci 1992, 649: 204-224.
4. MENON DK, PEDEN CJ, HAU AS, SARGENTONI J. WHITWAM JG. Magnetic resonance for the anaesthetist. Part 1: Physical principles, applications, safety aspects. Anaesthesia 1992, 47: 240-255.
5. BUDINGER TF. Emerging nuclear magnetic resonance technologies. Health and salety. Ann N Y Acad Sci 1992, 649.
6. ATHEY TW. Current FDA guidance for MR patient exposure and considerations for the future. Ann N Y Acad Sci 1992, 649.
7. GUÉNEL P. LELLOUCH J. Effets des champs électriques et magnétiques de très basse frequence sur la sante. Éditions INSERM, Paris, 1992.
8. CARR JJ. Magnetic resonance contrats agents for neuroimaging. Salety issues. Neuroimaging Clin N Am 1994, 4: 43-54.
9. RUNGE VM, GELBLUM DY, PACETTI ML CAROLAN F. HEARD G. Gd-HP-DO3A in clinical MR imaging of the brain. Radiology 1990, 177: 393-400.
10. BARNHART JL, KUHNERT N. BAKAN DA, BERK RN. Biodistribution of GdC13 and Gd- DTPA and their infl uenoe on proton magnetic relaxation in rat tissues. Magn Reson Imag 1987,5: 221-231.
1. KANAL E. Salety considerations in MR Imaging. Raliology 1990, 176: 593-606.
2. POHOST GM, BLACKWELL GG, SHEUOCK FG. Safety of patients with medical devices during application of magnetic resonance methods. Ann N Y Acad Sci 1992, 649: 302-312.
3. KANAL E. An overview of electromagnetic safety considerations associated with magnetic resonance imaging. Ann N Y Acad Sci 1992, 649: 204-224.
4. MENON DK, PEDEN CJ, HAU AS, SARGENTONI J. WHITWAM JG. Magnetic resonance for the anaesthetist. Part 1: Physical principles, applications, safety aspects. Anaesthesia 1992, 47: 240-255.
5. BUDINGER TF. Emerging nuclear magnetic resonance technologies. Health and salety. Ann N Y Acad Sci 1992, 649.
6. ATHEY TW. Current FDA guidance for MR patient exposure and considerations for the future. Ann N Y Acad Sci 1992, 649.
7. GUÉNEL P. LELLOUCH J. Effets des champs électriques et magnétiques de très basse frequence sur la sante. Éditions INSERM, Paris, 1992.
8. CARR JJ. Magnetic resonance contrats agents for neuroimaging. Salety issues. Neuroimaging Clin N Am 1994, 4: 43-54.
9. RUNGE VM, GELBLUM DY, PACETTI ML CAROLAN F. HEARD G. Gd-HP-DO3A in clinical MR imaging of the brain. Radiology 1990, 177: 393-400.
10. BARNHART JL, KUHNERT N. BAKAN DA, BERK RN. Biodistribution of GdC13 and Gd- DTPA and their infl uenoe on proton magnetic relaxation in rat tissues. Magn Reson Imag 1987,5: 221-231.